氧依赖性慢性阻塞性肺疾病对血管内动脉瘤修复术后囊 growth 与死亡率的影响
研究基于血管外科协会血管质量倡议数据库2010—2021年30,686例EVAR患者,按COPD严重程度(无、药物治疗、氧依赖)分析。氧依赖COPD与持续囊 growth 相关(平均差+0.55 mm,95%CI 0.05-1.05,P=0.03),再干预未增加(HR 0.82,95%CI 0.65-1.02,P=0.07),但死亡率显著升高(HR 1.8,95%CI 1.52-2.22,P<0.0001)。
要点
- 氧依赖COPD与EVAR术后1年持续囊 growth 独立相关,平均差+0.55 mm。
- 氧依赖COPD患者再干预率未显著增加(HR 0.82,95%CI 0.65-1.02,P=0.07)。
- 氧依赖COPD患者死亡率显著升高(HR 1.8,95%CI 1.52-2.22,P<0.0001)。
核心结论
- 氧依赖COPD与EVAR术后囊 growth 增加显著相关。
- 氧依赖COPD与再干预增加不相关,可能与该组死亡率不成比例升高有关。
- 氧依赖COPD患者预期寿命有限且囊重塑可能较差,择期EVAR应仅保留给AAA相关死亡风险最高的患者。
研究设计与样本
- 回顾性队列研究,纳入血管外科协会血管质量倡议数据库中2010—2021年全部EVAR患者。
- 共30,686例患者符合纳入标准。
- COPD严重程度(无、药物治疗、氧依赖)为主要暴露变量。
- 主要终点为EVAR术后1年囊 growth。
- 采用混合效应线性与逻辑回归评估COPD严重程度对囊重塑的影响并控制协变量,采用Cox比例风险回归和竞争风险回归识别死亡与再干预预测因素。
主要发现
- COPD患病率为24%:无COPD 75.8%(n=23,260),药物治疗COPD 19.7%(n=6,057),氧依赖COPD 4.5%(n=1,369)。
- 氧依赖COPD与EVAR植入后持续囊 growth 相关(平均差+0.55 mm,95%CI 0.05-1.05,P=0.03)。
- 药物治疗COPD与囊 growth 不相关(平均差-0.06 mm,95%CI -0.32至0.19,P=0.64)。
- 氧依赖COPD患者再干预率未增加(HR 0.82,95%CI 0.65-1.02,P=0.07)。
- 氧依赖COPD患者死亡率显著升高(HR 1.8,95%CI 1.52-2.22,P<0.0001)。
临床怎么用
- 作者认为氧依赖COPD患者预期寿命有限且囊重塑可能较差,择期EVAR应仅保留给AAA相关死亡风险最高的患者。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a known risk factor for abdominal aortic aneurysm (AAA) growth and rupture. The impact of COPD on AAA sac behavior following endovascular aneurysm repair (EVAR) is poorly understood. This study aimed to determine the association between COPD and sac remodeling after EVAR. METHODS: We identified all EVAR patients (2010-2021) in the Society for Vascular Surgery-Vascular Quality Initiative database. COPD severity (none, medication-treated, oxygen (O2)-dependent) was the primary exposure variable. The primary end point was 1-year sac growth post-EVAR. Mixed effects linear and logistic regression were used to assess the effects of COPD severity on sac remodeling, controlling for covariates. Cox proportional hazards regression and competing risks regression identified predictors of mortality and reintervention. RESULTS: 30,686 patients met inclusion criteria. COPD was present in 24% of patients (no COPD, 75.8% [n = 23,260], medication-treated COPD, 19.7% [n = 6,057], O2-dependent COPD, 4.5% [n = 1,369]). O2-dependent COPD was associated with persistent sac growth (mean difference: +0.55 mm, 95% confidence interval [CI] [0.05-1.05], P = 0.03) following EVAR implantation; however, medication-treated COPD was not (mean difference: -0.06 mm, 95% CI [-0.32 to 0.19]; P = 0.64). O2-dependent COPD patients did not experience increased reintervention rates (hazard ratio [HR] 0.82, 95% CI [0.65-1.02], P = 0.07) but were identified to have significantly increased mortality (HR 1.8, 95% CI [1.52-2.22], P < 0.0001). CONCLUSION: O2-dependent COPD was significantly associated with increased sac growth after EVAR. O2-dependent COPD did not correlate with increased reintervention, likely due to the disproportionately elevated mortality rates in this group. These findings highlight that patients with O2-dependent COPD have limited life expectancy and potentially less favorable sac remodeling, and elective EVAR should thus be reserved for only those at greatest risk for AAA-related mortality.
引用
- Bellamkonda KS, Suckow BD, Columbo JA, et al. The Implications of Oxygen-Dependent Chronic Obstructive Pulmonary Disease on Sac Growth and Mortality Following Endovascular Aneurysm Repair. Ann Vasc Surg. 2025. PMID: 40081526. doi:10.1016/j.avsg.2025.02.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。